Latent physiological factors of complex human diseases revealed by independent component analysis of clinarrays

BMC Bioinformatics

Volumn 11, Issue SUPPL. 9, 2010, Pages

  Chen, David P ^a,b,c   Dudley, Joel T ^a,b,c   Butte, Atul J ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD UREA NITROGENS; DUCHENNE MUSCULAR DYSTROPHIES; LABORATORY MEASUREMENTS; LARGE-SCALE ANALYSIS; MEDICAL PRACTITIONER; PARTICULAR CONDITION; PHYSIOLOGICAL FACTORS; VECTOR-BASED REPRESENTATIONS;

DISEASES; INDEPENDENT COMPONENT ANALYSIS; PHYSIOLOGY; RESEARCH LABORATORIES;

DIAGNOSIS;

BIOLOGICAL MARKER;

ARTICLE; CYSTIC FIBROSIS; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DOWN SYNDROME; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

BIOLOGICAL MARKERS; CYSTIC FIBROSIS; DIABETES MELLITUS, TYPE 2; DOWN SYNDROME; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES;

EID: 78049466272     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-11-S9-S4     Document Type: Article

References (31)

1. Raychaudhuri S, Stuart JM, Altman RB. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pacific Symposium on Biocomputing 2000, 455-466. 2669932, 10902193.
2. Liebermeister W. Linear modes of gene expression determined by independent component analysis. Bioinformatics 2002, 18(1):51-60. 10.1093/bioinformatics/18.1.51, 11836211.
3. Frigyesi A, Veerla S, Lindgren D, Höglund M. Independent component analysis reveals new and biologically significant structures in micro array data. BMC Bioinformatics 2006, 7:290. 10.1186/1471-2105-7-290, 1557674, 16762055.
4. Saidi SA, Holland CM, Kreil DP, MacKay DJ, Charnock-Jones DS, Print CG, Smith SK. Independent component analysis of microarray data in the study of endometrial cancer. Oncogene 2004, 23(39):6677-6683. 10.1038/sj.onc.1207562, 15247901.
5. Kiviniemi V, Kantola JH, Jauhiainen J, Hyvarinen A, Tervonen O. Independent component analysis of nondeterministic fMRI signal sources. Neuroimage 2003, 19(2 Pt 1):253-260. 10.1016/S1053-8119(03)00097-1, 12814576.
6. Comon P. Independent Component Analysis, a New Concept. Signal Processing 1994, 36(3):287-314.
7. Chen DP, Weber SC, Constantinou PS, Ferris TA, Lowe HJ, Butte AJ. Clinical Arrays of Laboratory Measures, or " Clinarrays" , Built from an Electronic Health Record Enable Disease Subtyping by Severity. 2007: American Medical Informatics Association 2007, 115.
8. Chen DP, WS, Constantinou PS, Ferris TA, Lowe HJ, Butte AJ. Novel Integration of hospital electronic medical records and gene expression measurements to identify genetic markers of maturation. Pacific Symposium on Biocomputing 2008, 243-254. 2716394, 18229690.
9. Chen DP, Morgan AA, Butte AJ. Validating pathophysiological models of aging using clinical electronic medical records. Journal of biomedical informatics 2009,
10. Fischbach FT, Dunning MB. A manual of laboratory and diagnostic tests. 2004, Philadelphia: Williams & Wilkins, 7th.
11. Leslie M. Cell biology. Beyond clotting: the powers of platelets. Science 2010, 328(5978):562-564. 10.1126/science.328.5978.562, 20430990.
12. Falco A, Romano M, Iapichino L, Collura M, Davi G. Increased soluble CD40 ligand levels in cystic fibrosis. Journal of Thrombosis and Haemostasis 2004, 2(4):557-560. 10.1111/j.1538-7836.2004.00683.x, 15102009.
13. O'Sullivan BP, Linden MD, Frelinger AL, Barnard MR, Spencer-Manzon M, Morris JE, Salem RO, Laposata M, Michelson AD. Platelet activation in cystic fibrosis. Blood 2005, 105(12):4635-4641. 10.1182/blood-2004-06-2098, 15705796.
14. Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, Niven RM, Economou G, Horrocks AW, Freemont AJ, Mawer EB, et al. Low bone mineral density in adults with cystic fibrosis. Thorax 1999, 54(11):961-967. 10.1136/thx.54.11.961, 1745400, 10525552.
15. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, Guise TA, Hardin DS, Haworth CS, Holick MF, et al. Consensus statement: Guide to bone health and disease in cystic fibrosis. Journal of Clinical Endocrinology and Metabolism 2005, 90(3):1888-1896. 10.1210/jc.2004-1629, 15613415.
16. Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, McCloskey N, Coker HA, Fear D, Smurthwaite L. The biology of IgE and the basis of allergic disease. Annual Review of Immunology 2003, 21:579-628. 10.1146/annurev.immunol.21.120601.141103, 12500981.
17. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 2005, 60(8):1004-1013. 10.1111/j.1398-9995.2005.00887.x, 15969680.
18. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, Strandvik B, McKenzie SG. Allergic bronchopulmonary aspergillosis in cystic fibrosis. European Respiratory Journal 2001, 17(5):1052-1053. 10.1183/09031936.01.17510520, 11488309.
19. Seldin DW, Tarail R. Effect of Hypertonic Solutions on Metabolism and Excretion of Electrolytes. American Journal of Physiology 1949, 159(1):160-174.
20. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: Evaluating the correction factor for hyperglycemia. American Journal of Medicine 1999, 106(4):399-403. 10.1016/S0002-9343(99)00055-8, 10225241.
21. Sterner G, Carlson J, Ekberg G. Raised platelet levels in diabetes mellitus complicated with nephropathy. Journal of Internal Medicine 1998, 244(6):437-441. 10.1111/j.1365-2796.1998.00349.x, 9893096.
22. Jesri A, Okonofua EC, Egan BM. Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. Journal of clinical hypertension 2005, 7(12):705-711. Greenwich, Conn, quiz 712-703, 10.1111/j.1524-6175.2005.04809.x, 16330892.
23. Leshin M. Polyglandular Autoimmune Syndromes. American Journal of the Medical Sciences 1985, 290(2):77-88. 10.1097/00000441-198508000-00007, 3898841.
24. Kordonouri O, Klinghammer A, Lang EB, Grabert M, Holl RW. Thyroid Autoimmunity in children and adolescents with type 1 diabetes mellitus: A multi-center survey. Diabetes 2002, 51:A52-A52.
25. Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB, Haffner SM. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes care 2007, 30(7):1819-1827. 10.2337/dc07-0086, 17429060.
26. EH R. Muscular Dystrophy. Pediatr Rev 2000, 21(7):233-237. 10.1542/pir.21-7-233, 10878185.
27. Perloff JK, Deleon AC, Odoherty D. Cardiomyopathy of Progressive Muscular Dystrophy. Circulation 1966, 33(4):625-648.
28. Young HL, Young W, Edelman IS. Electrolyte and lipid composition of skeletal and cardiac muscle in mice with hereditary muscular dystrophy. The American journal of physiology 1959, 197:487-490.
29. Wren TA, Bluml S, Tseng-Ong L, Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. Ajr 2008, 190(1):W8-12. 10.2214/AJR.07.2732, 18094282.
30. Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB. Missing value estimation methods for DNA microarrays. Bioinformatics 2001, 17(6):520-525. 10.1093/bioinformatics/17.6.520, 11395428.
31. Hyvarinen A. Fast and robust fixed-point algorithms for independent component analysis. Ieee Transactions on Neural Networks 1999, 10(3):626-634. 10.1109/72.761722, 18252563.